Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who were naive to anticholinergics before the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial may reflect patients seen in practice, in particular in primary care. In addition, investigating safety in these patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:NPJ Prim Care Respir Med
Egile Nagusiak: Wise, Robert, Calverley, Peter MA, Dahl, Ronald, Dusser, Daniel, Metzdorf, Norbert, Müller, Achim, Fowler, Andy, Anzueto, Antonio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634206/
https://ncbi.nlm.nih.gov/pubmed/26540491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2015.67
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak